Triptorelin


Indications and Reactions:

Role Indications Reactions
Secondary
Breast Cancer 53.4%
Prostate Cancer 13.6%
Hypertension 4.0%
Bone Loss 3.4%
Depression 3.4%
Antidepressant Therapy 2.8%
Chemotherapy 2.3%
Diabetes Mellitus 2.3%
Hormone Suppression Therapy 2.3%
Lymphangioleiomyomatosis 1.7%
Ovulation Induction 1.7%
Breast Cancer Female 1.1%
Hormone Replacement Therapy 1.1%
In Vitro Fertilisation 1.1%
Insomnia 1.1%
Neuritis 1.1%
Ovarian Failure 1.1%
Pancreatitis 1.1%
Atrial Fibrillation 0.6%
Gastritis Prophylaxis 0.6%
Pulmonary Embolism 12.8%
Skin Infection 10.3%
Erythema Multiforme 7.7%
Hypertransaminasaemia 7.7%
Neutropenia 7.7%
Vomiting 7.7%
Hepatic Failure 5.1%
Obesity 5.1%
Pneumonia 5.1%
Suicidal Ideation 5.1%
Acute Generalised Exanthematous Pustulosis 2.6%
Anxiety 2.6%
Bipolar Disorder 2.6%
Cerebrovascular Accident 2.6%
Cervical Polyp 2.6%
Coma 2.6%
Death 2.6%
Deep Vein Thrombosis 2.6%
Dyspareunia 2.6%
Ectopic Pregnancy 2.6%
Concomitant
Prostate Cancer 32.6%
Pain 7.2%
Prostate Cancer Metastatic 7.0%
Product Used For Unknown Indication 6.5%
Breast Cancer 5.4%
Prophylaxis 5.4%
Metastases To Bone 4.9%
Back Pain 4.7%
Hypertension 3.7%
Depression 2.8%
Neoplasm Malignant 2.6%
Insomnia 2.3%
Atrial Fibrillation 2.1%
Diabetes Mellitus 2.1%
Osteoporosis 2.1%
Sleep Disorder 2.1%
Hormone Therapy 1.9%
Cancer Pain 1.6%
Gastrointestinal Disorder Therapy 1.6%
Arthralgia 1.4%
Wheezing 13.8%
Vomiting 8.6%
Pancreatitis 6.9%
Sudden Cardiac Death 6.9%
General Physical Health Deterioration 5.2%
Hyperglycaemia 5.2%
Osteomyelitis 5.2%
Osteonecrosis Of Jaw 5.2%
Pelvic Venous Thrombosis 5.2%
Arthralgia 3.4%
Blood Alkaline Phosphatase Increased 3.4%
Electrocardiogram T Wave Inversion 3.4%
Gastritis Haemorrhagic 3.4%
Haematuria 3.4%
Liver Function Test Abnormal 3.4%
Proctitis 3.4%
Pruritus 3.4%
Rectal Cancer 3.4%
Sinus Bradycardia 3.4%
Skin Toxicity 3.4%

Drug Data